BIRC5 and cancer: Studies have revealed that the antiapoptotic protein survivin, a unique member in the inhibitor of apoptosis (IAP) family, is a pivotal molecule at the junction of cancer cell survival and division networks [1]–[3] and a critical inherent and induced drug/radiation resistance factor for various cancer types during treatment [4]–[12].